[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "BNT162b2", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "CoV2 preS dTM adjuvanted vaccine (B.1.351), Sanofi/GSK", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "CoV2 preS dTM adjuvanted vaccine (D614), Sanofi/GSK", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]

[{"arm_notes": "1, day 0, IM, 18-64 vs 65 older (Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination)", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "1, day 0, IM, 18-64 vs 65 older (Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination)", "treatment_id": 1932, "treatment_name": "Sars-cov-2 recombinant protein vaccine monovalent (d614)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "1, day 0, IM, 18-64 vs 65 older (Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination)", "treatment_id": 1933, "treatment_name": "Sars-cov-2 recombinant protein vaccine monovalent (b.1.351)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]